Efficacy of diversely isolated lytic phages against multi-drug resistant Enterobacter cloacae isolates in Kenya

African Journal of Laboratory Medicine

 
 
Field Value
 
Title Efficacy of diversely isolated lytic phages against multi-drug resistant Enterobacter cloacae isolates in Kenya
 
Creator Mutai, Ivy J. Juma, Angela A. Inyimili, Martin I. Nyachieo, Atunga Nyamache, Anthony K.
 
Subject — lytic phages; Enterobacter cloacae; multi-drug resistance; nosocomial infections; Nairobi County; Kenya
Description Background: Enterobacter cloacae causes nosocomial infections in 15% of patients in low- and middle-income countries with emergence of carbapenem resistance. The utilisation of bacteriophages for therapeutic purposes is crucial for eradicating these resistant bacterial strains.Objective: This study evaluated the efficacy of lytic phages on bacterial isolates of E. cloacae and determined their stability in various physicochemical conditions.Methods: Twenty-nine lytic phages were isolated from the waste water of six informal settlements in Nairobi County, Kenya, from July 2019 to December 2020 and cross-reacted with 30 anonymised clinical isolates of E. cloacae. Six phages were then selected for physicochemical property studies. Phages were described as potent upon lysing any bacterial strain in the panel.Results: Selected phages were stable at 4 °C – 50 °C with a 5.1% decrease in titre in four of six phages and a 1.8% increase in titre in two of six phages at 50 °C. The phages were efficient following two weeks incubation at 4 °C with optimal activity at human body temperature (37 °C) and an optimal pH of 7.5. Phages were active at 0.002 M and 0.015 M concentrations of Ca2+ ions. The efficiency of all phages decreased with increased exposure to ultraviolet light. All phages (n = 29) showed cross-reactivity against anonymised clinical isolates of E. cloacae strains (n = 30). The most potent phage lysed 67.0% of bacterial strains; the least potent phage lysed 27.0%.Conclusion: This study reveals the existence of therapeutic phages in Kenya that are potent enough for treatment of multi-drug resistant E. cloacae.
 
Publisher AOSIS
 
Contributor Ivy Mutai
Date 2022-08-11
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Literary analysis/literature review
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/ajlm.v11i1.1673
 
Source African Journal of Laboratory Medicine; Vol 11, No 1 (2022); 9 pages 2225-2010 2225-2002
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://ajlmonline.org/index.php/ajlm/article/view/1673/2338 https://ajlmonline.org/index.php/ajlm/article/view/1673/2339 https://ajlmonline.org/index.php/ajlm/article/view/1673/2340 https://ajlmonline.org/index.php/ajlm/article/view/1673/2341
 
Coverage — Global Environmental waste water
Rights Copyright (c) 2022 Ivy J. Mutai, Angela A. Juma, Martin I. Inyimili, Atunga Nyachieo, Anthony K. Nyamache https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT